FR377M - Médicament antibactérien a base de 2: 6-dihydroxy-4-(4'-hydroxyphénylazo)pyrimidine, ou de ses sels. - Google Patents

Médicament antibactérien a base de 2: 6-dihydroxy-4-(4'-hydroxyphénylazo)pyrimidine, ou de ses sels.

Info

Publication number
FR377M
FR377M FR837072A FR837072A FR377M FR 377 M FR377 M FR 377M FR 837072 A FR837072 A FR 837072A FR 837072 A FR837072 A FR 837072A FR 377 M FR377 M FR 377M
Authority
FR
France
Prior art keywords
hydroxyphenylazo
dihydroxy
pyrimidine
salts
drug based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837072A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR831871A external-priority patent/FR1432506A/fr
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to FR837072A priority Critical patent/FR377M/fr
Application granted granted Critical
Publication of FR377M publication Critical patent/FR377M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR837072A 1959-07-03 1960-08-29 Médicament antibactérien a base de 2: 6-dihydroxy-4-(4'-hydroxyphénylazo)pyrimidine, ou de ses sels. Active FR377M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837072A FR377M (fr) 1959-07-03 1960-08-29 Médicament antibactérien a base de 2: 6-dihydroxy-4-(4'-hydroxyphénylazo)pyrimidine, ou de ses sels.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB22904/59A GB876601A (en) 1959-07-03 1959-07-03 Pyrimidine derivatives
FR831871A FR1432506A (fr) 1960-07-02 1960-07-02 Procédé de fabrication de phénylazo- et de phénylhydrazo-pyrimidines
FR837072A FR377M (fr) 1959-07-03 1960-08-29 Médicament antibactérien a base de 2: 6-dihydroxy-4-(4'-hydroxyphénylazo)pyrimidine, ou de ses sels.

Publications (1)

Publication Number Publication Date
FR377M true FR377M (fr) 1961-04-04

Family

ID=10186945

Family Applications (1)

Application Number Title Priority Date Filing Date
FR837072A Active FR377M (fr) 1959-07-03 1960-08-29 Médicament antibactérien a base de 2: 6-dihydroxy-4-(4'-hydroxyphénylazo)pyrimidine, ou de ses sels.

Country Status (3)

Country Link
CH (1) CH410962A (fr)
FR (1) FR377M (fr)
GB (1) GB876601A (fr)

Also Published As

Publication number Publication date
CH410962A (de) 1966-04-15
GB876601A (en) 1961-09-06

Similar Documents

Publication Publication Date Title
FR264M (fr) Dérivés de 2,3-diméthoxy-benzohydroquinone-(1,4).
FR1038M (fr) Médicament a base d'aspirine.
FR3464M (fr) Médicament agissant sur le systeme nerveux central a base d'azaspiranes.
FR378M (fr) Médicament a base de 2-amino-7-méthyl-5-n-propyl-s-triazolo-[2,3-c]-pyrimidine a titre de bronchodilatateur.
OA00109A (fr) 3,4-dichloroanilides herbicides.
FR253M (fr) Dérivés de pyrimido-[5,4-d] pyrimidine.
FR377M (fr) Médicament antibactérien a base de 2: 6-dihydroxy-4-(4'-hydroxyphénylazo)pyrimidine, ou de ses sels.
FR147M (fr) N,n-diméthyl-2-phényl-2-benzoyloxyméthylbutylamine et ses sels d'addition.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR2258M (fr) Médicament destiné, en particulier, a combattre l'insomnie.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR24M (fr) Médicament a base de dérivé d'hyoscyamine.
FR3146M (fr) Nicotinate de di-isopropylamine.
FR1152M (fr) Médicament a base de dérivé la pyrimidine.
BE574575A (fr) Sels de polyméthylène bis-quinolinium et iso-quinolinium.
FR1453M (fr) Médicament analgéique, antithermique, antirhumatismal.
FR1293M (fr) Médicament a base de 1 α-méthyl-testostérone, utilisable comme anabolique.
FR1097M (fr) Médicament agissant sur la circulation sanguine, et a base de 1-(beta-n-propylamino-éthoxy)-2-éthoxy-5-propénylbenzene et de ses sels non toxiques.
FR1860M (fr) Médicament a base de lysergol substitué.
FR1345M (fr) Médicament a base de dérivé d'imino-dibenzyle.
FR1283M (fr) Médicaments diurétiques a base d'alkyl-2,2'-alkylene-bis-benzimidazoles ou de leurs sels d'addition d'acide.
FR1019M (fr) Médicament hypotenseur a base de benzylguanidines.
FR2119M (fr) La 1'allyl-4-phényl-4-carbopropoxypipéridine, et ses sels d'addition d'acides.
FR1043M (fr) Dérivé de la quinazolone et ses sels, utilisés en thérapeutique.
FR1995M (fr) Médicament a base de 2-aryl-4,7-diamino-(n-disubstitué-aminoalkyl)-6-ptéridine-carboxamides.